Comparison of histopathologic classification and surgical stage by cytokeratin 8 and cytokeratin 18 in endometrial cancer

European Journal of Gynaecological Oncology

Volumn 31, Issue 6, 2010, Pages 641-644

  Kabukcuoglu, S ^a   Ozalp, S S ^a   Yalcin, O T ^a   Colak, E ^a   Abubakar, A A ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

CK18; CK8; Endometrial cancer; Immunohistochemistry

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8; CYTOKERATIN ANTIBODY;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH VESSEL;

AGED; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-18; KERATIN-8; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 78751538200     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Crispens M.A.: "Endometrial cancer". In: Schorge J.O., Schaffer J.I., Halvarson L.M., Hoffman B.L., Bradshaw K.D., Cunningam F.G., Gary F. (eds.), Williams Gynecology, New York, McGraw Hill Medical, 2008, 687.
2. Kamoi S., Aljuboury M.I., Akin M.R., Silverberg S.G.: "Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocancers: Another viewpoint". Int. J. Gynaecol. Pathol., 2002, 21, 217.
3. Czemobilsky B., Mamet Y., David M.B., Atlas I., Gitstein G., Mercer B.L.: "Uterine retiform Sertoli-Leydig cell tumor report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors". Int. J. Gynaecol. Pathol, 2005, 24, 335.
4. Mol R., Divo M., Langbein L.: "The human keratins: biology and pathology". Histochem. Cell. Biol, 2008, 129, 705.
5. FIGO Committee on Gynecologic Oncology: "FIGO staging for uterine sarcomas, cancer of vulva, cancer of cervix uteri and cancer of endometrium". Int. J. Gynaecol. Obstet, 2009, 179, 104.
6. Spencer V.A., Coutts A.S., Samuel S.K., Murphy L.C., Davie J.R.: "Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells". J. Biol. Chem, 1998, 273, 29093.
7. Matthias C., Mack B., Berghaus A., Gires O.: "Keratin 8 expression in head and neck epithelia". BMC Cancer, 2008, 8, 267.
8. Kim M.A., Lee S.H., Yang H.K., Kim H.W.: "Cytokeratin expression profile in gastric cancers". Human Pathol., 2004, 35, 576.
9. Vos M.B., Barve S., Barve J.S., Carew J.D., Whitington P.F., McClain C.J.: "Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease". J. Pediatr. Gastroenterol. Nutr, 2008, 47, 481.
10. Lee J.C, Schickling O., Stegh A.H., Oshima R.G., Dinsdale D., Cohen G.M. et al.: "DEDD regulates degradation of intermediate filaments during apoptosis". J. Cell. Biol. 2002, 158, 1051.
11. Greystoke A., Cummings J., Ward T., Simpson K., Renehan A., Butt F.: "Optimisation of circulating biomarkers of cell death for routine clinical use". Ann. Oncol., 2008, 19, 990.
12. de Haas E.C., Pietro A., Simpson K.L., Meijer C., Suurmeijer A.J.H., Lancashire L.J. et al.: "Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer". Neoplasia, 2008, 10, 1041.
13. Choi D.S., Kim H.J., Yoon J.H, Yoo S.C., Jo H., Lee S.Y. et al:. "Endometrial cancer invasion depends on cancer - derived tumor necrosis factor - and stromal derived hepatocyte growth factor". Int. J. Cancer, 2009, 124, 2528.
14. Shah Y.M., Basrur V., Rowan B.G.: "Selective estrogen receptor modulator regulated proteins in endometrial cancer cells". Mol Cell. Endocrinol, 2004, 219, 127.
15. Czekierdowski A., Czekierdowska S., Czuba B., Cnota W., Sodowski K., Kotarski J. et al.: "Microvessel density assessment in benign and malignant endometrial changes". J. Physiol. Pharmacol., 2008, 59 (suppl. 4), 45.
16. Nunobiki O., Nakamura M., Taniguchi E., Utsunomiya H., Mori I, Tsubota Y et. al.: "Adrenomedullin, Bcl-2 and microvessel density in normal, hyperplastic and neoplastic endometrium". Pathol. International, 2009, 59, 530.
17. Kabukcuoglu S., Oner U., Ozalp S.S., Dundar E., Yalcin O.T., Colak E.: "Prognostic significance of fascine expression in endometrioid cancer". Eur. J. Gynaecol. Oncol, 2006, 2, 481.
18. Crispens M.A.: "Endometrial cancer". In: Rock J.A., Jones III. H.W. (eds.), Te Linde's Operative Gynecology, Philadelphia, Lippincott Wiliams & Wilkins, 2008, 1291.